Billionaire Profile
Noubar Afeyan
Global Rank
#2121

Image: Aleksey Chalabyan, a.k.a Xelgen | CC BY-SA 4.0 | via Wikimedia Commons

Noubar Afeyan

CEO, Biotech
UNITED STATES
Real-Time Net Worth
$1.907B
Estimated based on Biotech stock value as of March 6, 2026
-0.63% (24h)
Age
63
Source
Biotech
Industry
Healthcare
Citizenship
UNITED STATES

Biography

Noubar Afeyan is a prominent biotechnology innovator, entrepreneur, and philanthropist. Born in Beirut, Lebanon, in 1962, he is best known for co-founding Moderna, a pioneering messenger RNA vaccine company. He is the founder and CEO of Flagship Pioneering, a venture capital firm that has fostered over 100 scientific ventures. Afeyan has co-founded and helped build over 70 life science and technology startups. His achievements include authoring numerous scientific papers and holding over 100 patents. With a net worth of $296 million as of January 28, 2026, he is committed to philanthropy through the Afeyan Foundation and has pledged to donate the majority of his wealth.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Noubar Afeyan was born to Armenian parents in Beirut, Lebanon, in 1962. His family fled the Lebanese Civil War in 1975 and immigrated to Montreal, Canada. He graduated from Loyola High School in 1978 and later earned a B.Eng. in chemical engineering from McGill University in 1983. He then moved to the US and earned a Ph.D. in biochemical engineering from the Massachusetts Institute of Technology (MIT) in 1987.

Rise to Success

Inspired by a meeting with David Packard, Afeyan became an entrepreneur. He started his first biotechnology company in 1987 and has co-founded and helped build over 70 life science and technology startups. Afeyan founded Flagship Pioneering in 2000, which has developed more than 100 scientific ventures. In 2009, he co-founded Moderna, where he currently serves as chairman.

Key Business Strategies

Afeyan's business strategy centers on innovation and identifying seemingly unreasonable solutions to challenges in human health and sustainability. Flagship Pioneering focuses on creating first-in-category bioplatform companies. He is also known for his ability to identify and nurture promising startups in the biotechnology sector.

Philanthropy

Afeyan is committed to philanthropy. He co-founded the Aurora Humanitarian Initiative and the Armenian Spiritual Revival Foundation. His family's foundation, the Afeyan Foundation, had approximately $10 million in assets in 2024 and distributed nearly $3 million in grants that year. The Afeyans signed the Giving Pledge in 2025, committing the majority of their estimated fortune to philanthropy.

Career Milestones

1987

Founded First Biotechnology Company

Began his entrepreneurial journey in the biotech industry.

1988

Founded PerSeptive Biosystems

Served as CEO of a leader in bio-instrumentation.

1998

Senior VP and Chief Business Officer of Applera

Oversaw the creation of Celera Genomics after the acquisition of PerSeptive Biosystems.

2000

Founded Flagship Pioneering

Established a venture capital firm focused on biotechnology.

2009

Co-founded Moderna

Currently serves as Chairman of the Board.

Philanthropy & Social Impact

Humanitarian

Aurora Humanitarian Initiative

$2+ Billion

Co-founded to support human rights defenders.

Philanthropic Grants

Afeyan Foundation

$3 Million (Grants in 2024)

Supports various causes with an emphasis on science, education, and global humanitarian initiatives.

Science and Technology

FAST Foundation

N/A

Founding angel of Foundation for Armenian Science and Technology.

Business Philosophy & Leadership

Notable Quotes

"“What keeps you from innovating is being comfortable. If you're an immigrant, then you're used to being out of your comfort zone,”"

"“We believe that invention can be a force for good—science and technology deployed with empathy.”"

Leadership Principles

Innovation and Invention

Focus on creating and funding novel solutions in biotechnology.

Entrepreneurial Mindset

Embracing skills and practices that can be professionalized and taught.

Philanthropy and Giving Back

Believing that privilege comes with responsibility and that giving is a form of invention.

Controversies & Challenges

2022

Moderna CFO Ousting

Moderna's new CFO Jorge Gomez was ousted after one day on the job, legal constraints prevented Moderna from finding out about an internal investigation launched by Gomez's last employer, Dentsply, until last week.